Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4964844 [patent_doc_number] => 20080107664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Method For Increasing Cd8+ Cytotoxic T Cell Responses And For Treating Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 10/575831 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6339 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107664.pdf [firstpage_image] =>[orig_patent_app_number] => 10575831 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575831
Method For Increasing Cd8+ Cytotoxic T Cell Responses And For Treating Multiple Sclerosis Oct 17, 2004 Abandoned
Array ( [id] => 13165 [patent_doc_number] => 07807377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Method of isolating antigen-specific T cells employing artificial antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 10/960855 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 77 [patent_no_of_words] => 47344 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807377.pdf [firstpage_image] =>[orig_patent_app_number] => 10960855 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/960855
Method of isolating antigen-specific T cells employing artificial antigen presenting cells Oct 5, 2004 Issued
Array ( [id] => 7252531 [patent_doc_number] => 20050142587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Mammalian genes; related reagents and methods' [patent_app_type] => utility [patent_app_number] => 10/960450 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25308 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142587.pdf [firstpage_image] =>[orig_patent_app_number] => 10960450 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/960450
Mammalian genes; related reagents and methods Oct 5, 2004 Abandoned
Array ( [id] => 7252157 [patent_doc_number] => 20050074805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Specific markers for diabetes' [patent_app_type] => utility [patent_app_number] => 10/952459 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7272 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074805.pdf [firstpage_image] =>[orig_patent_app_number] => 10952459 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952459
Specific markers for diabetes Sep 27, 2004 Abandoned
Array ( [id] => 5807702 [patent_doc_number] => 20060094056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/514701 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 48304 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094056.pdf [firstpage_image] =>[orig_patent_app_number] => 10514701 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514701
Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases Sep 14, 2004 Abandoned
Array ( [id] => 7116241 [patent_doc_number] => 20050069542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Antibodies that specifically bind to GMAD' [patent_app_type] => utility [patent_app_number] => 10/935290 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60332 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069542.pdf [firstpage_image] =>[orig_patent_app_number] => 10935290 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/935290
Antibodies that specifically bind to GMAD Sep 7, 2004 Issued
Array ( [id] => 5070157 [patent_doc_number] => 20070191259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Inhibition of s6 kinaze activity for the treatment of insulin resistance' [patent_app_type] => utility [patent_app_number] => 10/568637 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11654 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191259.pdf [firstpage_image] =>[orig_patent_app_number] => 10568637 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568637
Inhibition of s6 kinaze activity for the treatment of insulin resistance Aug 19, 2004 Abandoned
Array ( [id] => 5068943 [patent_doc_number] => 20070190044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal' [patent_app_type] => utility [patent_app_number] => 10/568127 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28330 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190044.pdf [firstpage_image] =>[orig_patent_app_number] => 10568127 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568127
Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal Aug 11, 2004 Abandoned
Array ( [id] => 4812826 [patent_doc_number] => 20080193457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Ra Antigenic Peptides' [patent_app_type] => utility [patent_app_number] => 10/567386 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29736 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193457.pdf [firstpage_image] =>[orig_patent_app_number] => 10567386 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/567386
Ra Antigenic Peptides Jul 29, 2004 Abandoned
Array ( [id] => 7152501 [patent_doc_number] => 20050025758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Method and compositions for treatment of insulin-dependant diabetes mellitus' [patent_app_type] => utility [patent_app_number] => 10/867149 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7353 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025758.pdf [firstpage_image] =>[orig_patent_app_number] => 10867149 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/867149
Method and compositions for treatment of insulin-dependant diabetes mellitus Jun 13, 2004 Abandoned
Array ( [id] => 7181282 [patent_doc_number] => 20040202660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Methods and compositions for treatment of immune dysfunction disorders' [patent_app_type] => new [patent_app_number] => 10/470981 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202660.pdf [firstpage_image] =>[orig_patent_app_number] => 10470981 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/470981
Methods and compositions for treatment of immune dysfunction disorders May 19, 2004 Abandoned
Array ( [id] => 9551720 [patent_doc_number] => 08758767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/557273 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22312 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10557273 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557273
Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof May 19, 2004 Issued
Array ( [id] => 5799361 [patent_doc_number] => 20060034864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors' [patent_app_type] => utility [patent_app_number] => 10/847139 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17074 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034864.pdf [firstpage_image] =>[orig_patent_app_number] => 10847139 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/847139
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors May 16, 2004 Abandoned
Array ( [id] => 7089089 [patent_doc_number] => 20050009202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods and compositions for use in the diagnosis and treatment of chronic immune disease' [patent_app_type] => utility [patent_app_number] => 10/845777 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17042 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009202.pdf [firstpage_image] =>[orig_patent_app_number] => 10845777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845777
Methods and compositions for use in the diagnosis and treatment of chronic immune disease May 12, 2004 Abandoned
Array ( [id] => 7060502 [patent_doc_number] => 20050002862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 10/845473 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9950 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002862.pdf [firstpage_image] =>[orig_patent_app_number] => 10845473 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845473
Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders May 11, 2004 Abandoned
Array ( [id] => 7033700 [patent_doc_number] => 20050032210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Method of preparing immuno-regulatory dendritic cells and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/835591 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 18727 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032210.pdf [firstpage_image] =>[orig_patent_app_number] => 10835591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835591
Method of preparing immuno-regulatory dendritic cells and the use thereof Apr 29, 2004 Abandoned
Array ( [id] => 7317469 [patent_doc_number] => 20040224304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'ApoCIII and the treatment and diagnosis of diabetes' [patent_app_type] => new [patent_app_number] => 10/834525 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7664 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224304.pdf [firstpage_image] =>[orig_patent_app_number] => 10834525 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834525
Methods for identifying compounds for treating type 1 diabetes Apr 28, 2004 Issued
Array ( [id] => 7263665 [patent_doc_number] => 20040241763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Method for diagnosing multiple sclerosis' [patent_app_type] => new [patent_app_number] => 10/835607 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12207 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241763.pdf [firstpage_image] =>[orig_patent_app_number] => 10835607 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835607
Method for diagnosing multiple sclerosis Apr 27, 2004 Abandoned
Array ( [id] => 6958491 [patent_doc_number] => 20050214861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Human hematopoietic stem and progenitor antigen and methods for its use' [patent_app_type] => utility [patent_app_number] => 10/827907 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14445 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214861.pdf [firstpage_image] =>[orig_patent_app_number] => 10827907 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/827907
Human hematopoietic stem and progenitor antigen and methods for its use Apr 18, 2004 Abandoned
Array ( [id] => 7088999 [patent_doc_number] => 20050009112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth' [patent_app_type] => utility [patent_app_number] => 10/796905 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14946 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009112.pdf [firstpage_image] =>[orig_patent_app_number] => 10796905 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/796905
Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth Mar 7, 2004 Abandoned
Menu